Advertisement
Skip to Content

Janus Henderson Global Life Sciences S JFNSX

Quantitative rating as of | See Janus Henderson Investment Hub
  • NAV / 1-Day Return 64.05  /  0.47 %
  • Total Assets 4.7 Bil
  • Adj. Expense Ratio
    1.180%
  • Expense Ratio 1.180%
  • Distribution Fee Level Above Average
  • Share Class Type No Load
  • Category Health
  • Investment Style Large Blend
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 0.00
  • Turnover 21%

Morningstar’s Analysis JFNSX

Will JFNSX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Summary

|

Janus Henderson Global Life Sciences S’s management team is just average, but a solid investment process still helps this strategy retain its Morningstar Quantitative Rating of Bronze. Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.

Unlock our full analysis with Morningstar Investor